G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in August
Aug 06, 2019 - GlobeNewswire
RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the company will participate in two investor conferences in August 2019.
The company will meet with investors at the 2019 BTIG Biotechnology Conference on Monday, August 12 at the St. Regis New York in New York, NY.Chief Executive Officer Mark Velleca, M.D., Ph.D. will present a company overview at the 2019 Wedbush PacGrow Healthcar...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
